Laura van ‘t Veer amongst 15 trailblazers in oncology honored on the 2020 digital awards ceremony

IRVINE, Calif., Oct. 28, 2020 /CNW/ — Agendia, Inc., a world chief in precision oncology for breast most cancers, right now introduced that co-founder and Chief Analysis Officer Laura van ‘t Veer, PhD, will probably be inducted as this 12 months’s Most cancers Diagnostics honoree to the 2020 class of OncLive’s® Giants of Most cancers Care® in a digital awards ceremony on Thursday, November 5, 2020, at 7:30PM EST.

(PRNewsfoto/Agendia Inc.)

Extra

People named Giants of Most cancers Care have reached landmark successes inside the world area of oncology and their work has considerably impacted affected person care and analysis. Out of 818 nominations, solely 15 had been chosen to this 12 months’s class.

“It’s a distinct privilege to be counted amongst so many paramount members of the oncology neighborhood,” stated Dr. van ‘t Veer. “Though we won’t rejoice in individual this 12 months, I stay up for connecting nearly to acknowledge our collective accomplishments and focus on how we are going to proceed our work to enhance affected person outcomes and construct the library of information that may assist us battle most cancers.”

OncLive is the nation’s main multimedia useful resource specializing in offering oncology professionals with related, insightful info on affected person care. The group’s Giants of Most cancers Care program has celebrated greater than 98 oncology legends since 2013 for his or her ground-breaking achievements in oncology analysis and medical apply.

“Dr. van ‘t Veer, together with the opposite members of the 2020 class embody what it means to be a Large of Most cancers Care,” stated Mike Hennessy Jr., president and CEO of MJH Life Sciences



, the dad or mum firm of OncLive®. “Her in depth background and unbelievable dedication to making sure every affected person receives the most effective therapy, was actually the driving pressure behind the event of MammaPrint. We’re proud to acknowledge wonderful, dynamic and well-versed oncology leaders like Dr. van ‘t Veer who’re making nice contributions to the sphere.”

For extra info, or to register to attend the digital awards ceremony, click on right here.

About Agendia

Agendia is a precision oncology firm headquartered in Irvine, California, dedicated to bringing early stage breast most cancers sufferers and their physicians the data they should make the best therapy choices. The corporate at present provides two commercially-available genomic profiling assessments, supported by medical and actual world proof. MammaPrint®, the 70-gene breast most cancers recurrence assay, and BluePrint®, the 80-gene molecular subtyping assay, present a complete genomic profile and the information physicians must make extra knowledgeable choices within the pre- and post-operative therapy settings. By creating evidence-based novel genomic assessments and conducting groundbreaking analysis whereas constructing an arsenal of information that may assist deal with most cancers, Agendia goals to enhance affected person outcomes and assist the evolving medical wants of breast most cancers sufferers and their physicians each step of the best way, from preliminary prognosis to cancer-free.

About OncLive®

OncLive® is a digital platform of assets providing oncology professionals the data they should present the most effective affected person care. OncLive® is a model of MJH Life Sciences



, the biggest privately held, unbiased, full-service medical media firm in North America devoted to delivering trusted well being care information throughout a number of channels.

Story continues